The global Interventional Oncology Market is set for steady expansion, fueled by the rising global cancer burden and the increasing adoption of minimally invasive, image-guided procedures. The market, valued at USD 2,341.4 million in 2024, is projected to grow to USD 3,414.1 million by 2032, demonstrating a Compound Annual Growth Rate (CAGR) of 4.91% over the...